Paper33490296
Allogeneic Umbilical Cord Blood-Derived Mesenchymal Stem Cell Implantation Versus Microfracture for Large, Full-Thickness Cartilage Defects in Older Patients: A Multicenter Randomized Clinical Trial and Extended 5-Year Clinical Follow-up.
Lim HC and 13 others. Orthop J Sports Med, 2021. Cited by 84 papers, by iCite.
Cite this record
ConductScience Library. Allogeneic Umbilical Cord Blood-Derived Mesenchymal Stem Cell Implantation Versus Microfracture for Large, Full-Thickness Cartilage Defects in Older Patients: A Multicenter Randomized Clinical Trial and Extended 5-Year Clinical Follow-up. Papers, record 33490296. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33490296
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Allogeneic Umbilical Cord Blood-Derived Mesenchymal Stem Cell Implantation Versus Microfracture for Large, Full-Thickness Cartilage Defects in Older Patients: A Multicenter Randomized Clinical Trial and Extended 5-Year Clinical Follow-up.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Trials2
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT01041001 | Study to Compare Efficacy and Safety of Cartistem and Microfracture in Patients With Knee Articular Cartilage Injury | Derived from the trial | Yes | ClinicalTrials.gov |
| NCT01626677 | Follow-Up Study of CARTISTEM® Versus Microfracture for the Treatment of Knee Articular Cartilage Injury or Defect | Derived from the trial | Yes | ClinicalTrials.gov |
References49
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16581448 | Cartilage healing after microfracture in osteoarthritic knees. | Arthroscopy | 2006 | https://conductscience.org/library/papers/16581448 | PubMed |
| 2 | 20392971 | Autologous bone marrow-derived mesenchymal stem cells versus autologous chondrocyte implantation: an observational cohort study. | Am J Sports Med | 2010 | https://conductscience.org/library/papers/20392971 | PubMed |
| 3 | 28148266 | Restoration of a large osteochondral defect of the knee using a composite of umbilical cord blood-derived mesenchymal stem cells and hyaluronic acid hydrogel: a case report with a 5-year follow-up. | BMC Musculoskelet Disord | 2017 | https://conductscience.org/library/papers/28148266 | PubMed |
| 4 | 3068365 | Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. | J Rheumatol | 1988 | https://conductscience.org/library/papers/3068365 | PubMed |
| 5 | 19251676 | Clinical efficacy of the microfracture technique for articular cartilage repair in the knee: an evidence-based systematic analysis. | Am J Sports Med | 2009 | https://conductscience.org/library/papers/19251676 | PubMed |
| 6 | 23224561 | Clinical outcome following the first-line, single lesion microfracture at the knee joint. | Arch Orthop Trauma Surg | 2013 | https://conductscience.org/library/papers/23224561 | PubMed |
| 7 | 28191757 | Cartilage Regeneration in Osteoarthritic Patients by a Composite of Allogeneic Umbilical Cord Blood-Derived Mesenchymal Stem Cells and Hyaluronate Hydrogel: Results from a Clinical Trial for Safety and Proof-of-Concept with 7 Years of Extended Follow-Up. | Stem Cells Transl Med | 2017 | https://conductscience.org/library/papers/28191757 | PubMed |
| 8 | 17002893 | Treatment of a full-thickness articular cartilage defect in the femoral condyle of an athlete with autologous bone-marrow stromal cells. | Osteoarthritis Cartilage | 2007 | https://conductscience.org/library/papers/17002893 | PubMed |
| 9 | 22588746 | Measures of knee function: International Knee Documentation Committee (IKDC) Subjective Knee Evaluation Form, Knee Injury and Osteoarthritis Outcome Score (KOOS), Knee Injury and Osteoarthritis Outcome Score Physical Function Short Form (KOOS-PS), Knee Outcome Survey Activities of Daily Living Scale (KOS-ADL), Lysholm Knee Scoring Scale, Oxford Knee Score (OKS), Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), Activity Rating Scale (ARS), and Tegner Activity Score (TAS). | Arthritis Care Res (Hoboken) | 2011 | https://conductscience.org/library/papers/22588746 | PubMed |
| 10 | 17917891 | UC blood-derived mesenchymal stromal cells: an overview. | Cytotherapy | 2007 | https://conductscience.org/library/papers/17917891 | PubMed |
| 11 | 11603719 | Microfracture: surgical technique and rehabilitation to treat chondral defects. | Clin Orthop Relat Res | 2001 | https://conductscience.org/library/papers/11603719 | PubMed |
| 12 | 23680930 | Treatment of knee osteoarthritis with autologous mesenchymal stem cells: a pilot study. | Transplantation | 2013 | https://conductscience.org/library/papers/23680930 | PubMed |
| 13 | 17084294 | Is microfracture of chondral defects in the knee associated with different results in patients aged 40 years or younger? | Arthroscopy | 2006 | https://conductscience.org/library/papers/17084294 | PubMed |
| 14 | 16410387 | Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. | Stem Cells | 2006 | https://conductscience.org/library/papers/16410387 | PubMed |
| 15 | 11573919 | Development and validation of the international knee documentation committee subjective knee form. | Am J Sports Med | 2001 | https://conductscience.org/library/papers/11573919 | PubMed |
| 16 | 15512914 | Mesenchymal stem/progenitor cells developed in cultures from UC blood. | Cytotherapy | 2004 | https://conductscience.org/library/papers/15512914 | PubMed |
| 17 | 11869080 | Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees. | Osteoarthritis Cartilage | 2002 | https://conductscience.org/library/papers/11869080 | PubMed |
| 18 | 25318414 | Cartilage repair and subchondral bone remodeling in response to focal lesions in a mini-pig model: implications for tissue engineering. | Tissue Eng Part A | 2015 | https://conductscience.org/library/papers/25318414 | PubMed |
| 19 | 20844166 | Autologous chondrocyte implantation: a systematic review. | J Bone Joint Surg Am | 2010 | https://conductscience.org/library/papers/20844166 | PubMed |
| 20 | 24646697 | Comparison of articular cartilage repair with different hydrogel-human umbilical cord blood-derived mesenchymal stem cell composites in a rat model. | Stem Cell Res Ther | 2014 | https://conductscience.org/library/papers/24646697 | PubMed |
Cited by59
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 84 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42959448 | Therapeutic potential of umbilical cord-derived MSCs in arthritis: Insights from preclinical and clinical studies. | Regen Ther | 2026 | https://conductscience.org/library/papers/42959448 | PubMed |
| 42859758 | Comprehensive regulatory and developmental landscape of cell-scaffold combination therapies for osteoarthritis. | Regen Ther | 2026 | https://conductscience.org/library/papers/42859758 | PubMed |
| 42644960 | MSC-Hydrogel Composite Systems for Knee Cartilage Repair and Osteoarthritis: A Systematic Review. | Gels | 2026 | https://conductscience.org/library/papers/42644960 | PubMed |
| 42299644 | Natural Biomaterials for Osteochondral Repair: From Source to Strategy. | Adv Healthc Mater | 2026 | https://conductscience.org/library/papers/42299644 | PubMed |
| 42278268 | Current State of Orthobiologics in Treatment of Knee Osteoarthritis-Future Directions. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42278268 | PubMed |
| 42270934 | Next-generation therapies for osteoarthritis: the evolving role of cell therapy products. | Exp Mol Med | 2026 | https://conductscience.org/library/papers/42270934 | PubMed |
| 42148296 | Limitations in the clinical translation of mesenchymal stromal cells: standardisation, heterogeneity and the recipient. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42148296 | PubMed |
| 42082961 | Role of external forces in the mechanobiology of stem and differentiated chondrogenic cells embedded in a tissue-engineered construct for cartilage repair. | J Biomed Sci | 2026 | https://conductscience.org/library/papers/42082961 | PubMed |
| 42062571 | First-in-human and multicenter phase I study of OSCA therapy for knee osteoarthritis. | Exp Mol Med | 2026 | https://conductscience.org/library/papers/42062571 | PubMed |
| 41869895 | Engineering Approaches to Modify Immunomodulatory Functions of Mesenchymal Stromal Cells (MSCs): Tissue Regeneration and Clinical Application. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/41869895 | PubMed |
| 41767232 | The osteochondral regeneration paradox: why biomimetic scaffolds are biologically superior but injectable systems dominate the clinic. | RSC Adv | 2026 | https://conductscience.org/library/papers/41767232 | PubMed |
| 41737547 | Global Panoramic analysis of clinical research in cell therapy: clinical trial landscape, marketed products, and regulatory trends. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/41737547 | PubMed |
| 41299567 | Stem cell revolution: bridging the gap between research and clinical application. | Stem Cell Res Ther | 2025 | https://conductscience.org/library/papers/41299567 | PubMed |
| 40932934 | The potential of mitochondrial transfer as the modifying therapy for osteoarthritis. | Front Cell Dev Biol | 2025 | https://conductscience.org/library/papers/40932934 | PubMed |
| 40671230 | hUCB-MSCs Secreted Exosomal miR-21-5p Promotes Vascular Endothelial Tip Cell Proliferation and Migration by Downregulating TGF-β1. | Curr Stem Cell Res Ther | 2026 | https://conductscience.org/library/papers/40671230 | PubMed |
| 40565176 | Co-Culture Approaches in Cartilage and Bone Tissue Regeneration. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40565176 | PubMed |
| 40447967 | Emerging Therapy in Osteoarthritis: Mesenchymal Stem Cells, Secretomes, and Using Hydrogels to Enhance Efficacy. | BioDrugs | 2025 | https://conductscience.org/library/papers/40447967 | PubMed |
| 40281581 | Effectiveness and safety of multiple injections of human placenta-derived MSCs for knee osteoarthritis: a nonrandomized phase I trial. | BMC Musculoskelet Disord | 2025 | https://conductscience.org/library/papers/40281581 | PubMed |
| 40169165 | Stem cell injections for osteoarthritis of the knee. | Cochrane Database Syst Rev | 2025 | https://conductscience.org/library/papers/40169165 | PubMed |
| 40124721 | Requirements for standardizing the assessment of mesenchymal stem cell therapy and its effects on osteoarthritis. | World J Orthop | 2025 | https://conductscience.org/library/papers/40124721 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CRP | 1401 | PubTator's text mining | https://conductscience.org/library/genes/1401 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33490296
GET https://conductscience.org/api/papers/v1/33490296/references?page=2